MedPal AI Soars on AIM — Is This the Next Major Wellness Tech Play
MedPal AI has captured investor attention with a share price that’s tripled since its AIM debut. CEO Jason Drummond, a seasoned entrepreneur with multiple IPOs under his belt, is betting big on an AI-powered wellness app that aims to disrupt the booming digital health market. In this interview, he discusses MedPal’s mission, the path to monetisation.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
